Both in Medical Labs
Guardant Health vs CareDx
Over the past year GH returned +76.9% and CDNA returned +499.0%; their daily moves had a correlation of 0.26.
GH +76.9% CDNA +499.0%Growth of $1, one year, split-adjusted
| Metric | GH | CDNA |
|---|---|---|
| Price | $175.00 | $88.47 |
| Market cap | $23.48B | $4.65B |
| Today | +2.50% | +3.02% |
| 1 month | −6.5% | +26.7% |
| 6 months | +95.5% | +327.4% |
| Year to date | +71.3% | +369.6% |
| 1 year | +88.1% | +489.8% |
| Revenue growth (YoY) | +44.3% | +39.3% |
| Gross margin | 65.4% | 71.1% |
| Net margin | −35.9% | 13.8% |
| P/E (TTM) | — | 36.1× |
| Price / sales | 19.8× | 9.3× |
| Net cash | -$449.5M | $250.5M |
| Dividend yield | — | — |
| Volatility (60d) | 44.4% | 61.8% |
| Short % of float | 9.2% | 13.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).